Marietta Investment Partners’s Halozyme HALO Stock Holding History

Marietta Investment Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.55M	Sell	45,382 -3,660	-7%	-$250K	0.61%	47
2026 Q1	$3.17M	Buy	49,042 +13,741	+39%	+$969K	0.63%	48
2025 Q4	$2.38M	Buy	35,301 +6,150	+21%	+$414K	0.47%	59
2025 Q3	$2.14M	Buy	29,151 +330	+1%	+$21.9K	0.41%	62
2025 Q2	$1.5M	Buy	28,821 +12,420	+76%	+$707K	0.33%	68
2025 Q1	$1.05M	Hold	16,401	–	–	0.25%	79
2024 Q4	$784K	Sell	16,401 -52,728	-76%	-$2.7M	0.17%	95
2024 Q3	$3.96M	Buy	69,129 +40,887	+145%	+$2.34M	0.84%	37
2024 Q2	$1.48M	Buy	+28,242	New	+$1.24M	0.32%	66

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marietta Investment Partners's HALO Position: Q2 2026 in Review

Marietta Investment Partners reduced its Halozyme (HALO) stake by 7.5% in Q2 2026, selling an estimated $250K and leaving 45,382 shares worth $3.55M. The position accounts for 0.61% of the portfolio, ranked #47.

Marietta Investment Partners first reported a position in HALO in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.96M in Q3 2024. 569 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Marietta Investment Partners held 45,382 shares of Halozyme worth $3.55M as of Q2 2026.
Marietta Investment Partners sold 3,660 Halozyme shares in Q2 2026, an estimated $250K.
Halozyme made up 0.61% of Marietta Investment Partners's portfolio in Q2 2026, its #47 holding.
Marietta Investment Partners first reported a position in Halozyme in Q2 2024 and has held it in 9 quarters since.
Marietta Investment Partners's Halozyme position peaked at $3.96M in Q3 2024.
569 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Marietta Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.